4.7 Letter

On the SARS-CoV-2 BA.2.86 lineage: a mutation point of view

Related references

Note: Only part of the references are listed.
Article Virology

Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages

Fabio Scarpa et al.

Summary: Recombination is the main driver of RNA virus evolution, and during the pandemic, SARS-CoV-2 produced several recombinants. The most recent recombinant, XBB or Gryphon, is a combination of BJ.1 and BM.1.1.1 lineages. Genetic analysis revealed that XBB and its descendant XBB.1 have slightly higher genetic variability and expansion capabilities compared to their parental lineages. However, they do not currently pose a specific danger or have high expansion capabilities. Ongoing genome-based monitoring is necessary to identify if further mutations in XBB could increase its danger or generate new subvariants with different expansion capabilities.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Microbiology

Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5

Fabio Scarpa et al.

Summary: Since the beginning of the pandemic, new variants have been emerging, and the XBB.1.5 SARS-CoV-2 variant is one of the most recent. This study aimed to assess the potential hazard of this new subvariant using a comprehensive approach that integrates genetic variability, phylodynamics, and structural/immunoinformatic analyses. The findings suggest that XBB.1.5 spreads more slowly compared to previous concerning variants and does not pose a high risk of viral expansion.

MICROORGANISMS (2023)

Review Virology

Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2

Marta Giovanetti et al.

Summary: This comprehensive review focuses on the impact of SARS-CoV-2 as the cause of the COVID-19 pandemic. It covers the virus's epidemic history, evolutionary aspects, and implications for public health. The review emphasizes the importance of genomic surveillance in tracking viral mutations and implementing public health interventions.

JOURNAL OF MEDICAL VIROLOGY (2023)

Editorial Material Virology

The unresolved question on COVID-19 virus origin: The three cards game?

Alessandra Borsetti et al.

Summary: The debate over the origin of SARS-CoV-2 continues, with no solid evidence to support the theory that it is man-made and lab-leak theories remaining speculative. The consensus is that the pandemic likely originated from a natural source and further research is needed to determine the true origin of the virus.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Multidisciplinary Sciences

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Akatsuki Saito et al.

Summary: During the COVID-19 pandemic, the B.1.617.2/Delta variant has been found to be highly fusogenic and more pathogenic in infected hamsters compared to prototypic SARS-CoV-2. The P681R mutation in the spike protein of this variant enhances viral fusogenicity and pathogenicity.

NATURE (2022)

Article Cell Biology

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Yang Liu et al.

Summary: This study reports that the P681R mutation in the Delta spike plays a crucial role in the replacement of the Alpha variant by the Delta variant during the COVID-19 pandemic. The Delta variant outcompetes the Alpha variant in human lung cells and airway tissues. The P681R mutation enhances the cleavage of the spike protein, leading to increased replication of the Delta variant.

CELL REPORTS (2022)

Review Microbiology

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Lanying Du et al.

NATURE REVIEWS MICROBIOLOGY (2009)